SEARCH

SEARCH BY CITATION

References

  • Algvere PV, von Wendt G, Gudmundsson J, Seregard S & Kvanta A (2009): Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin). Acta Ophthalmol [Epub ahead of print].
  • Angulo Bocco MC, Glacet-Bernard A, Zourdani A, Coscas G & Soubrane G (2008): [Intravitreous injection: retrospective study on 2028 injections and their side effects]. J Fr Ophtalmol 31: 693698.
  • Branch Vein Occlusion Study Group (1984): Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 98: 271282.
  • Campochiaro PA, Hafiz G, Shah SM et al. (2008): Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 16: 791799.
  • Central Vein Occlusion Study Group (1995): Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 102: 14251433.
  • Central Vein Occlusion Study Group (1997): Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 115: 486491.
  • Chung EJ, Hong YT, Lee SC, Kwon OW & Koh HJ (2008): Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246: 12411247.
  • Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F & Samama MM (1996): Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103: 551560.
  • Goff MJ, Jumper JM, Yang SS, Fu AD, Johnson RN, McDonald HR & Ai E (2006): Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina 26: 896901.
  • Heier JS, Antoszyk AN, Pavan PR et al. (2006): Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 113: 633. e631–634.
  • Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU & Szurman P (2009): One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247: 2733.
  • Kim KS, Chang HR & Song S (2008): Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion. Acta Ophthalmol 86: 925927.
  • Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W & Schmidt-Erfurth U (2008): Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92: 518522.
  • Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y & Adamis AP (2000): Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156: 17331739.
  • Noma H, Funatsu H, Yamasaki M et al. (2005): Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140: 256261.
  • Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H & Mishima HK (2006): Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244: 309315.
  • Pieramici DJ, Rabena M, Castellarin AA et al. (2008): Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Ophthalmology 115: e47e54.
  • Rensch F, Jonas JB & Spandau UH (2009): Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion. Acta Ophthalmol 87: 7781.
  • Shima C, Sakaguchi H, Gomi F et al. (2008): Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86: 372376.
  • Shimura M, Nakazawa T, Yasuda K, Kunikata H, Shiono T & Nishida K (2008): Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 86: 377384.
  • Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB & Klein R (2009): Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 147: 298306.
  • Williamson TH & O’Donnell A (2005): Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 139: 860866.